The ACRx prescription discount card program is raising its first major institutional funding round — advised by Stifel Financial — to scale America's most trusted nonprofit prescription access network.
Official Major Teaser · October 3, 2024 · Stifel Financial Corp. — Exclusive Financial Advisor
Watch the pitch · then apply below
Growth capital to scale America's most trusted prescription discount network — with institutional-grade oversight from Stifel Financial.
Scale national digital marketing and card distribution infrastructure
Expand proprietary AI-driven pharmacy pricing engine
Hire executive sales force for B2B and municipal partnerships
Strategic acquisition of regional PBM networks to increase margin per transaction
Revenue generated via standard PBM adjudication fee paid to ACRx for every transaction processed using Group ACRX103. Zero cost to cardholder.
Post-funding projections based on scaled distribution of Group ACRX103 cards via digital, B2B, and community channels.
| Period | Cards Distributed | Projected Revenue | YoY Growth |
|---|---|---|---|
| Year 1 (Post-Funding) | 30,000,000 | $48,500,000 | Baseline |
| Year 2 | 45,000,000 | $82,000,000 | +69% |
| Year 3 | 65,000,000 | $145,000,000 | +77% |
SMS, QR codes, and social channels enable card distribution at near-zero cost per acquisition.
Existing relationships with 50,000+ nonprofits, churches, schools, and hospitals provide instant distribution channels.
Prescription demand is structurally inelastic. Economic downturns increase card adoption as budgets tighten.
Physical or digital card shared via community, nonprofit, and digital channels
Member uses card at any of 67,000+ participating pharmacies
$2.75 adjudication fee paid by the PBM to ACRx per prescription processed
Revenue flows to program, investors, and community partners
Founded 2004. Established PBM relationships, BIN/PCN infrastructure, and 25M+ cards already in circulation. This is not a startup — it's a scaled, validated network seeking growth capital.
Nonprofit structure drives higher consumer trust and lower user acquisition costs. Legacy BIN/PCN data eliminates pharmacy onboarding friction entirely.
Prescription demand is structurally inelastic regardless of economic climate. Downturns increase card adoption as patient budgets tighten — making this countercyclical.
Strong ESG credentials under LTC La Daryl Franklin's leadership. 50,000+ nonprofits, churches, schools, and hospitals already distributing the card create a self-reinforcing distribution moat.
Stifel Financial Corp. serves as exclusive lead financial advisor and placement agent for this growth capital round. This institutional-grade oversight facilitates institutional investor entry and provides a clear exit strategy targeting strategic acquisition by a major healthcare aggregator or PBM — targeting 5–8x ROIC.
Full deck covering market opportunity, financials, partnership structure, and growth roadmap.
Full investor deck covering market opportunity, ACRx partnership structure, financial projections, and distribution roadmap.
View Full PresentationAmerican Consultants Rx (ACRX) engages experienced legal counsel to support the structuring, negotiation, and execution of institutional capital transactions.
Upon execution of a mutual non-disclosure agreement (NDA) with a prospective funding source, qualified parties may be introduced into a formal due diligence and negotiation process.
Legal representation for ACRX includes Fox Rothschild LLP, which may participate in the review, structuring, and negotiation of transactions in coordination with ACRX leadership.
All funding discussions, terms, and transaction structures are subject to formal negotiation and documentation, with final approval and execution authority retained by the Chief Executive Officer and Founder of American Consultants Rx.
Engagement in discussions following NDA execution does not constitute a commitment to transact. All potential transactions remain subject to due diligence, legal review, and mutual agreement between the parties.
Our team typically responds within 24 hours.